Diana Boraschi, Paola Bossù, Giovanni Macchia, Paolo Ruggiero & Aldo Tagliabue

Dept. Biotechnology, Research Center Dompé SpA, Via Campo di Pile, I-67100 L'Aquila Italy

Received 8/5/96; Accepted 9/11/96; On-line 11/01/96

4. REFERENCES

1. J. J. Oppenheim & I. Gery: Interleukin 1 is more than an interleukin. Immunology Today 3, 113-9 (1982)

2. C. A. Dinarello: Interleukin-1. Rev Infect Dis 6, 51-95 (1984)

3. J. J. Oppenheim, E. J. Kovacs, K. Matsushima & S. K. Durum: There is more than one interleukin 1. Immunology Today 7, 45-56 (1986)

4. C. A. Dinarello: Interleukin-1 and its biologically related cytokines. Adv Immunol 44, 153-203 (1989)

5. F. Di Giovine & G. W. Duff: Interleukin 1: the first interleukin. Immunology Today 11, 13-20 (1990)

6. C. A. Dinarello: The interleukin-1 family: 10 years of discovery. FASEB J 8, 1314-25 (1990)

7. C. A. Dinarello: Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-52 (1991)

8. C. A. Dinarello: The biological properties of interleukin-1. Eur Cytokine Net 5, 517-31 (1994)

9. C. A. Dinarello: Biologic basis for interleukin-1 in disease. Blood 87, 2095-147 (1996)

10. S. P. Eisenberg, M. T. Brewer, E. Verderber, P. Heimdal, B. J. Brandhuber & R. C. Thompson: Interleukin 1 receptor antagonist is a member of the interleukin 1 family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 88, 5232-6 (1991)

11. M. J. H. Nicklin, A. Weith & G. W. Duff: A physical map of the region encompassing the human interleukin-1alpha, interleukin-1ß, and interleukin-1 receptor antagonist genes. Genomics 19, 382-4 (1994)

12. S. Haskill, G. Martin, L. Van Le, J. Morris, A. Peace, G. J. Jaffe, C. Hammerberg, S. A. Sporn, S. Fong & W. P. Arend: cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 88, 3681-5 (1991)

13. M Muzio, N. Polentarutti, M. Sironi, G. Poli, L. De Gioia, M. Introna, A. Mantovani & F. Colotta: Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J Exp Med 182, 623-8 (1995)

14. J. P. Priestle, H.-P. Schär & M. G. Grütter: Crystallographic refinement of interleukin 1b at 2.0 Å resolution. Proc Natl Acad Sci USA 86, 9667-71 (1989)

15. B. C. Finzel, L. L. Clancy, D. R. Holland, S. W. Muchmore, K. D. Watenpaugh & H. M. Einsphar: Crystal structure of recombinant human interleukin-1ß at 2.0 Å resolution. J Mol Biol 209, 779-91 (1989)

16. B. J. Graves, M. H. Hatada, W. A. Hendrickson, J. K. Miller, V. S. Madison & Y. Satow: Structure of interleukin 1a at 2.7-Å resolution. Biochemistry 29, 2679-84 (1990)

17. A. G. Murzin, A. M. Lesk & C. Chothia: b-trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1ß and 1a and Fibroblast Growth Factors. J Mol Biol 223, 531-43 (1992)

18. G. P. A. Vigers, P. Caffes, R. J. Evans, R. C. Thompson, S. P. Eisenberg & B. J. Brandhuber: X-ray structure of interleukin-1 receptor antagonist at 2.0 Å resolution. J Biol Chem 269, 12874-9 (1994)

19. B. J. Stockman, T. A. Scahill, N. A. Strakalaitis, D. P. Brunner A. W. Yem & M. R. Deibel Jr: Solution structure of human interleukin-1 receptor antagonist protein. FEBS Lett 349, 79-83 (1994)

20. R. A. Black, S. R. Kronheim, M. Cantrell, M. C. Deeley, C. J. March, K. S. Prickett, J. Wignall, P. J. Conlon, D. Cosman, T. P. Hopp & D. Y. Mochizuki: Generation of biologically active interleukin-1ß by proteolytic cleavage of the inactive precursor. J Biol Chem 263, 9437-42 (1988)

21. D. P. Cerretti, C. J. Kozlosky, B. Mosley, N. Nelson, K. Van Ness, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner & R. A. Black: Molecular cloning of the interleukin-1ß converting enzyme. Science 256, 97-100 (1992)

22. N. A. Thornberry, H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, K. O. Elliston, J. M. Ayala, F. J. Casano, J. Chin, J.-F. Ding, L. A. Egger, E. P. Gaffney, G. Limjuco, O. C. Palyha, S. M. Raju, A. M. Rolando, J. P. Salley, T.-T. Yamin, T. D. Lee, J. E. Shively, M. MacCross, R. A. Mumford, J. A. Schmidt & M. J. Tocci: A novel heterodimeric cysteine protease is required for interleukin-1ß processing in monocytes. Nature 356, 768-74 (1992)

23. D. J. Hazuda, J. Strickler, P. Simon & P. R. Young: Structure-function mapping of interleukin 1 precursors. Cleavage leads to conformational change in the mature protein. J Biol Chem 266, 7081-6 (1991)

24. M. Irmler, S. Hertig, H. R. MacDonald, R. Sadoul, J. D. Becherer, A. Proudfoot, R. Solari & J. Tschopp: Granzyme A is an interleukin 1b-converting enzyme. J Exp Med 181, 1917-22 (1995)

25. J. Yuan, S. Shaham, S. Ledoux, H. M. Ellis & H. R. Horvitz: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1ß- converting enzyme. Cell 75, 641-52 (1993)

26. S. Kumar & M. F. Lavin: The ICE family of cysteine proteases as effectors of cell death. Cell Death Diff in press (1996)

27. J. W. Lowenthal & H. R. MacDonald: binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J Exp Med 164, 1060-74 (1986)

28. S. K. Dower & D. L. Urdal: The interleukin-1 receptor. Immunology Today 8, 46-51 (1987)

29. J. E. Sims, C. J. March, D. Cosman, M. B. Widmer, H. R. MacDonald, C. J. McMahan, C. E. Grubin, J. M. Wignall, J. L. Jackson, S. M. Call, D. Friend, A. R. Alpert, S. Gillis, D. L. Urdal & S. K. Dower: cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241, 585-9 (1988)

30. J. E. Sims & S. K. Dower: Interleukin-1 receptors. Eur Cytokine Net 5, 539-46 (1994)

31. D. P. Cerretti, L. T. Hollingsworth, C. J. Kozlosky, M. B. Valentine, D. N. Shapiro, S. W. Morris & N. Nelson: Molecular characterization of the gene for human interleukin-1ß converting enzyme (IL1bC). Genomics 20, 468-73 (1994)

32. C. J. McMahan, J. L. Slack, B. Mosley, D. Cosman, S. D. Lupton, L. L. Brunton, C. E. Grubin, J. M. Wignall, N. A. Jenkins, C. I. Brannan, N. G. Copeland, K. Huebner, C. M. Croce, L. A. Cannizzaro, D. Benjamin, S. K. Dower, M. K. Spriggs & J. E. Sims: A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10, 2821-32 (1991)

33. L. A. J. O'Neill, T. A. Bird & J. Saklatvala: Interleukin 1 signal transduction. Immunology Today 11, 392-4 (1990)

34. B. Rossi: IL-1 transduction signals. Eur Cytokine Net 4, 181-7 (1993)

35. J. W. Brooks & S. B. Mizel: Interleukin-1 signal transduction. Eur Cytokine Net 5, 547-61 (1994)

36. S. C. Greenfeder, P. Nunes, L. Kwee, M. Labow, R. A. Chizzonite & G. Ju: Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 270, 13757-65 (1995)

37. D. Burger, R. Chicheportiche, J. G. Giri & J.-M. Dayer: The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest 96, 38-41 (1995)

38. F. Colotta, S. K. Dower, J. E. Sims & A. Mantovani: The type II "decoy" receptor: a novel regulatory pathway for interleukin-1. Immunology Today 15, 562-6 (1994)

39. J. A. Symons, P. R. Young & G. W. Duff: Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1ß precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci USA 92, 1714-8 (1995)

40. W. P. Arend, M. Malyak, M. F. Smith Jr, T. D. Whisenand, J. L. Slack, J. E. Sims, J. G. Giri & S. K. Dower: Binding of IL-1alpha, IL-1ß, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 153, 4766-74 (1994)

41. J. G. Giri, J. Wells, S. K. Dower, C. E. McCall, R. N. Guzman, J. Slack, T. A. Bird, K. Shanebeck, K. H. Grabstein, J. E. Sims & M. R. Alderson: Elevated levels of shed type II receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol 153, 5802-9 (1994)

42. P. Bossù, U. Visconti, P. Ruggiero, G. Macchia, M. Muda, R. Bertini, C. Bizzarri, A. Colagrande, V. Sabbatini, G. Maurizi, E. Del Grosso, A. Tagliabue & D. Boraschi: Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am J Pathol 147, 1852-61 (1995)

43. M. Baggiolini, B. Dewald & B. Moser: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55, 97-179 (1994)

44. G. C. Bagby Jr: Interleukin-1 and hematopoiesis. Blood Rev 82, 152-61 (1989)

45. W. Brugger, W. Möcklin, S. Heimfeld, R. J. Berenson, R. Mertelsmann & L. Kanz: Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1ß (IL-1ß), IL-6, IL-3, interferon-g, and erythropoietin. Blood 81, 2579-84 (1993)

46. M. J. Staruch & D. D. Wood: The adjuvanticity of interleukin 1 in vivo. J Immunol 130, 2191-4 (1983)

47. L. Nencioni, L. Villa, A. Tagliabue, G. Antoni, R. Presentini, F. Perin, S. Silvestri & D. Boraschi: In vivo immunostimulating activity of the 163-171 peptide of human IL-1ß. J Immunol 139, 800-4 (1987)

48. D. Frasca, D. Boraschi, S. Baschieri, P. Bossù, A. Tagliabue, L. Adorini & G. Doria: In vivo restoration of T cell functions by human IL-1ß or its 163-171 nonapeptide in immunodepressed mice. J Immunol 141, 2651-5 (1988)

49. F. Coceani: Prostaglandins and fever. In: Fever: basic mechanisms and management. Ed: Machowiak P, Raven Press, NY (1991)

50. J. A. M. Maier, P. Voulalas, D. Roeder & T. Maciag: Extension of the life-span of human endothelial cells by an interleukin-1alpha antisense oligomer. Science 249, 1570-4 (1990)

51. A. M. Zubiaga, E. Muñoz & B. T. Huber: Production of IL-1alpha by activated Th type 2 cells. Its role as an autocrine growth factor. J Immunol 146, 3849-56 (1991)

52. H. U. Beuscher & H. R. Colten: Structure and function of membrane IL-1. Mol Immunol 25, 1189-99 (1988)

53. W. Falk & R. Hofmeister: Intracellular IL-1 replaces signaling by the membrane IL-1 type I receptor. Cytokine 6, 558 (1994)

54. C. J. Fisher Jr, J.-F. Dhainaut, S. M. Opal, J. P. Pribble, R. A. Balk, G. J. Slotman, T. J. Iberti, E. C. Rackow, M. J. Shapiro, R. L. Greenman, H. D. Reines, M. P. Shelly, B. W. Thompson, J. F. LaBrecque, M. A. Catalano, W. A. Knaus & J. C. Sadoff: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. JAMA 271, 1836-43 (1994)

55. D. Boraschi & A. Tagliabue: Structure-function relationship of interleukin-1 giving new insights for its therapeutic potential. Biotherapy 1, 337-89 (1989)

56. H. Kawashima, J.-i. Yamagishi, M. Yamayoshi, M. Ohue, T. Fukui, H. Kotani & M. Yamada: Structure-activity relationship in human interleukin-1alpha: identification of key residues for expression of biological activities. Prot Engineer 5, 171-6 (1992)

57. M. Yamayoshi, M. Ohue, H. Kawashima, M. Iida, S. Kawata & M. Yamada: An unique derivative of human IL-1alpha lacking PGE₂ production. In: The Physiological and Pathological Effects of Cytokines. Ed: Dinarello C. A., Wiley-Liss, NY (1990)

58. E. Labriola-Tompkins, C. Chandran, T. A. Varnell, V. S. Madison & G. Ju: Structure-function analysis of human IL-1alpha: identification of residues required for binding to the human type I IL-1 receptor. Prot Engineer 6, 535-9 (1993)

59. R. B. Gayle III, K. Pointdexter, D. Cosman, S. K. Dower, S. Gillis, T. Hopp, R. Jerzy, S. Kronheim, V. Lum, A. Lewis, M. M. Goodgame, C. J. March, D. L. Smith & S. Srinivasan: Identification of regions in interleukin-1alpha important for activity. J Biol Chem 268, 22105-11 (1993)

60. S. D. Yanofsky & G. Zurawski: Identification of key residues in the amino-terminal third of human interleukin-1alpha. J Biol Chem 265, 13000-6 (1990)

61. P. T. Wingfield, R. J. Mattaliano, H. R. MacDonald, S. Craig, G. M. Clore, A. Gronenborn & U. Schmeissner: Recombinant-derived interleukin-1alpha stabilized against specific deamidation. Prot Engineer 1, 413-7 (1987)

62. P. T. Wingfield, M. Payton, P. Graber, K. Rose, J.-M. Dayer, A. R. Shaw & U. Schmeissner: Purification and characterization of human interleukin-1alpha produced in Escherichia coli. Eur J Biochem 165: 537-41 (1987)

63. S. Nakai, M. Kaneta, Y. Kikumoto, Y.-M. Hong, K. Kawai, S. Takegata, K. Ishii & Y. Yanagihara: Polypeptide having modified IL-1alpha structure, useful as immune system stimulants and anti-inflammatory agents. Patents EP 0237073 A2 (1987) and 9118 US 5008374 (1987)

64. A. M. Gronenborn, P. T. Wingfield, H. R. MacDonald, U. Schmeissner & G. M. Clore: Site directed mutagenesis of human interleukin-1alpha: a 1H-NMR and receptor binding study. FEBS Lett 231, 135-8 (1988)

65. M. Yamayoshi, M. Ohue, H. Kawashima, H. Kotani, M. Iida, S. Kawata & M. Yamada: A human IL-1alpha derivative which lacks prostaglandin E₂ inducing activity and inhibits the activity of IL-1 through receptor competition. Lymphokine Res 9, 405-13 (1990)

66. B. Mosley, S. K. Dower, S. Gillis & D. Cosman: Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1a and 1b. Proc Natl Acad Sci USA 84, 4572-6 (1987)

67. S. M. Zurawski, K. Pope, H. Cherwinski & G. Zurawski: Expression in Escherichia coli of synthetic human interleukin-1alpha genes encoding the processed active protein, mutant proteins, and b-galactosidase fusion proteins. Gene 49, 61-8 (1986)

68. S. Nakai, Y. Masui, T. Kamoto, K. Aihara, Y. Himeda & Y. Hirai: Pharmaceutical compositions containing IL-1 derivatives as human IL-6 inducers. Patent JP 03197433 A2 (1991)

69. J. J. Huang, R. C. Newton, R. Horuk, J. B. Matthew, M. Covington, K. Pezzella & Y. Lin: Muteins of human interleukin-1 that show enhanced bioactivity. FEBS Lett 223, 294-8 (1987)

70. P. L. Simon, V. Kumar, J. S. Lillquist, P. Bhatnagar, R. Einstein, J. Lee, T. Porter, D. Green, G. Sathe & P. R. Young: Mapping of neutralizing epitopes and the receptor binding site of human interleukin 1b. J Biol Chem 268, 9771-9 (1993)

71. T. Kamogashira, M. Sakaguchi, Y. Ohmoto, K. Mizuno, R. Shimizu, K. Nagamura, S. Nakai & Y. Hirai: Site specific mutagenesis of the human interleukin-1ß gene: the role of arginine residue at the N-terminal region. J Biochem 104, 837-40 (1988)

72. E. Labriola-Tompkins, C. Chandran, K. L. Kaffka, D. Biondi, B. J. Graves, M. Hatada, V. S. Madison, J. Karas, P. L. Kilian & G. Ju: Identification of the discontinuous binding site in human interleukin 1b for the type I interleukin 1 receptor. Proc Natl Acad Sci USA 88, 11182-6 (1991)

73. S. Nakai, K. Kawai, Y. Hirai & K. Tasaka: A mutant protein of human interleukin-1ß with immunostimulatory but not pyrogenic potency. Life Sci 47,1707-14 (1990)

74. Y. Naito, J. Fukata, Y. Masui, Y. Hirai, N. Murakami, T. Tominaga, Y. Nakai, S. Tamai, K. Mori & H. Imura: Interleukin-1ß analogues with markedly reduced pyrogenic activity can stimulate secretion of adrenocorticotropic hormone in rats. Biochem Biophys Res Commun 167, 103-9 (1990)

75. M. G. Grütter, J. van Oostrum, J. P. Priestle, E. Edelmann, U. Joss, U. Feige, K. Vosbeck & A. Schmitz: A mutational analysis of receptor binding sites of interleukin-1ß: differences in binding of human interleukin-1ß muteins to human and mouse receptors. Prot Engineer 7, 663-71 (1994)

76. J. B. Baumann, E. Christen, G. Gamboni, U. Joss, J. van Oostrum, J. Girard & A. N. Eberle: Receptor binding and biological activity of IL-1alpha, IL-1ß, IL-1ß analogues and IL-1 antagonist in A375 human melanoma cells. J Receptor Res 13, 245-62 (1993)

77. E. Palla, G. Bensi, E. Solito, D. Tornese Buonamassa, G. Fassina, G. Raugei, F. Spano, C. Galeotti, M. Mora, M. Domenighini, M. Rossini, E. Gallo, V. Carinci, M. Bugnoli, F. Bertini, L. Parente & M. Melli: Loop substitution as a tool to identify active sites of interleukin-1ß. J Biol Chem 268, 13486-92 (1993)

78. D.-C. Ambrosetti, E. Palla, A. Mirtella, C. Galeotti, E. Solito, P. Navarra, L. Parente and M. Melli: Synthetic alleles at position 121 define a functional domain of human interleukin-1ß. Eur J Biochem in press (1996)

79. T. Kamogashira, Y. Masui, Y. Ohmoto, T. Hirato, K. Nagamura, K. Mizuno, Y.-M. Hong, Y. Kikumoto, S. Nakai & Y. Hirai: Site specific mutagenesis of the human interleukin-1ß gene: structure-function analysis of the cysteine residues. Biochem Biophys Res Commun 150, 1106-14 (1988)

80. F. Folliard, N. Touchet & B. Terlain: Comparison of the binding of IL-1 and mutants on lymphocytes and chondrocytes and their effects on some biological activities. Discovery of an IL-1ß mutant with dissociated properties. J Leuk Biol S1, 51 (1990)

81. N. P. Camacho, D. R. Smith, A. Goldman, B. Schneider, D. Green, P. R. Young & H. M. Berman: Structure of an Interleukin-1ß mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein-protein recognition. Biochemistry 32, 8749-57 (1993)

82. S. P. Eisenberg, R. J. Evans, J. D. Childs, B. J. Brandhuber & R. C. Thompson: Role of specific IL-1ß and IL-1ra residues analyzed by site directed mutagenesis. Cytokine 3, 500 (1991)

83. R. J. Evans, J. Bray, J. D. Childs, G. P. A. Vigers, B. J. Brandhuber, J. J. Skalicky, R. C. Thompson & S. E. Eisenberg: Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1ß by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1ß. J Biol Chem 270, 11477-83 (1995)

84. P. E. Auron, G. J. Quigley, L. J. Rosenwasser & L. Gehrke: Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1ß protein. Biochemistry 31, 6632-8 (1992)

85. L. Gehrke, S. A. Jobling, L. S. K. Paik, B. McDonald, L. J. Rosenwasser & P. E. Auron: A point mutation uncouples interleukin-1ß biological activity and receptor binding. J Biol Chem 265, 5922-5 (1990)

86. W. Conca, P. E. Auron, M. Aoun-Wathne, N. Bennett, P. Seckinger, H. G. Welgus, S. R. Goldring, S. P. Eisenberg, J.-M. Dayer, S. M. Krane & L. Gehrke. 1991: An interleukin 1b point mutant demonstrates that jun/fos expression is not sufficient for fibroblast metalloproteinase expression. J Biol Chem 266, 16265-8 (1991)

87. D. Boraschi, P. Bossù, P. Ruggiero, A. Tagliabue, R. Bertini, G. Macchia, C. Gasbarro, L. Pellegrini, G. Melillo, E. Ulisse, U. Visconti, C. Bizzarri, E. Del Grosso, A. R. Mackay, G. Frascotti, F. Frigerio, R. Grifantini & G. Grandi: Mapping of receptor binding sites on IL-1ß by reconstruction of IL-1ra-like domains. J Immunol 155, 4719-25 (1995)

88. H. R. MacDonald, P. Wingfield, U. Schmeissner, A. Shaw, G. M. Clore & A. M. Gronenborn: Point mutations of human interleukin-1 with decreased receptor binding affinity. FEBS Lett 209, 295-8 (1986)

89. A. M. Gronenborn, G. M. Clore, U. Schmeissner and P. Wingfield: A 1H-NMR study of human interleukin-1ß. Sequence-specific assignment of aromatic residues using site-directed mutant proteins. Eur J Biochem 161, 37-43 (1986)

90. B. Veerapandian: Modified interleukin-1ß. Patent PCT/US92/00662 (1992)

91. A. Simoncsits, J. Bristulf, M. L. Tjörnhammar, M. Cserzö, S. Pongor, E. Rybakina, S. Gatti & T. Bartfai: Deletion mutants of human interleukin 1b with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors. Cytokine 6: 206-14 (1994)

92. K. Mizuno & Y. Hirai: IL-1ß derivatives labeled with radioactive iodine and their preparation. Patent JP 02169600 A2 (1990)

93. S. Nakai, M. Kaneta, Y. Kikumoto, Y.-M. Hong, K. Kawai, S. Takegata, K. Ishii, Y. Yanagihara & Y. Hirai: IL-1ß derivatives and drugs. Patent EP 0237967 A2 (1987)

94. S. Tate, Y. Kikumoto, S. Ichikawa, M. Kaneko, Y. Masui, T. Kamogashira, M. Ouchi, S. Takahashi & F. Inagaki: Stable isotope aided nuclear magnetic resonance study to investigate the receptor-binding site of human interleukin 1b. Biochemistry 31, 2435-42 (1992)

95. J.-Y. Chang, P. K. Ngai, J. P. Priestle, U. Joss, K. D. Vosbeck & J. van Oostrum: Identification of a reactive lysyl residue (Lys103) of recombinant human interleukin-1ß. Mechanism of its reactivity and implication of its functional role in receptor binding. Biochemistry 31, 2874-8 (1992)

96. B. Veerapandian, G. L. Gilliland, R. Raag, A. L. Svensson, Y. Masui, Y. Hirai & T. L. Poulos: Functional implications of interleukin-1ß based on the three-dimensional structure. Proteins Struct Funct Genet 12, 10-23 (1992)

97. P. Wingfield, P. Graber, A. R. Shaw, A. M. Gronenborn, G. M. Clore & H. R. MacDonald: Preparation, characterization and application of interleukin-1ß mutant proteins with surface-accessible cysteine residues. Eur J Biochem 179, 565-71 (1989)

98. G. Ju, E. Labriola-Tompkins, C. A. Campen, W. R. Benjamin, J. Karas, J. Plocinski, D. Biondi, K. L. Kaffka, P. L. Kilian, S. P. Eisenberg & R. J. Evans: Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Proc Natl Acad Sci USA 88, 2658-62 (1991)

99. T. Kamoto, K. Mizuno, K. Yamanishi & Y. Hirai: Human IL-1ß derivatives recombinant manufacture as pharmaceuticals for treatment of disorders associated with excess IL-1ß. Patent JP 02223597 A2 (1990)

100. A. W. Yem, K. A. Richards, N. D. Staite & M. R. Deibel Jr: Resolution and biological properties of three N-terminal analogues of recombinant human interleukin-1ß. Lymphokine Res 7, 85-92 (1988)

101. Y. Kikumoto, Y.-M. Hong, T. Nishida, S. Nakai, Y. Masui & Y. Hirai: Purification and characterization of recombinant human interleukin-1ß produced in Escherichia coli. Biochem Biophys Res Commun 147, 315-21 (1987)

102. P. Wingfield, P. Graber, N. R. Movva, A. M. Gronenborn & H. R. MacDonald: N-terminal methionylated interleukin-1ß has reduced receptor binding affinity. FEBS Lett 215: 160-4 (1987)

103. R. Horuk, J. J. Huang, M. Covington & R. C. Newton: A biochemical and kinetic analysis of the interleukin-1 receptor. Evidence for differences in molecular properties of IL-1 receptors. J Biol Chem 262, 16275-8 (1987)

104. J. R. Zucali, J. Moreb, R. C. Newton & J. J. Huang: Human N-terminal analogs of interleukin 1b demonstrate altered binding and function in hematopoiesis. Exp Hematol 18, 1078-82 (1990)

105. H. Imura, J. Fukata & Y. Hirai: A derivative of IL-1ß for testing the ACTH-secreting function of the anterior pituitary. Patent EP 0360226 A2 (1990)

106. J. S. Lillquist, P. L. Simon, M. Summers, Z. Jonak & P. R. Young: Structure-activity studies of human IL-1ß with mature and truncated proteins expressed in Escherichia coli. J Immunol 141, 1975-81 (1988)

107. S. A. Jobling, P. E. Auron, G. Gurka, A. C. Webb, B. McDonald, L. J. Rosenwasser & L. Gehrke: Biological activity and receptor binding of human prointerleukin-1ß and subpeptides. J Biol Chem 263, 16372-8 (1988)

108. L. J. Rosewasser, A. C. Webb, B. D. Clark, S. Irie, L. Chang, C. A. Dinarello, L. Gehrke, S. M. Wolff, A. Rich & P. E. Auron: Expression of biologically active human interleukin 1 subpeptides by transfected simian COS cells. Proc Natl Acad Sci USA 83, 5243-6 (1986)

109. J. J. Huang, R. C. Newton, K. Pezzella, M. Covington, T. Tamblyn, S. J. Rutlege, J. Gray, M. Kelley & Y. Lin: High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1ß. Mol Biol Med 4,169-81 (1987)

110. C. A. Meyers, K. O. Johanson, L. M. Miles, P. J. McDevitt, P. L. Simon, R. L. Webb, M.-J. Chen, B. P. Holskin, J. S. Lillquist & P. R. Young: Purification and characterization of human recombinant interleukin-1ß. J Biol Chem 262, 11176-81 (1987)

111. F. Guinet, T. Cartwright, J. D. Guitton & B. Terlain: Polypeptides derived from interleukin-1ß, method for the preparation and utilisation thereof, particularly for osteoarticular pathologies. Patent PCT/FR91/00779 (1991)

112. J. Fukada, H. Imura & Y. Hirai: Human IL-1ß and/or its derivatives for prevention and recovery promotion of secondary adrenocortical insufficiency. Patent JP 03093726 A2 (1991)

113. S. A. Greenfeder, T. Varnell, G. Powers, K. Lombard-Gillooly, D. Shuster, K. W. McIntyre, D. E. Ryan, W. Levin, V. Madison & G. Ju: Insertion of a structural domain of interleukin (IL)-1ß confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity. J Biol Chem 270, 22460-6 (1995)

114. G. Antoni, R. Presentini, F. Perin, A. Tagliabue, P. Ghiara, S. Censini, G. Volpini, L. Villa & D. Boraschi: A short synthetic fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol 137, 3201-4 (1986)

115. D. Boraschi, L. Nencioni, L. Villa, S. Censini, P. Bossù, P. Ghiara, R. Presentini, F. Perin, D, Frasca, G. Doria, G. Forni, T. Musso, M. Giovarelli, P. Ghezzi, R. Bertini, H. O. Besedovsy, A. del Rey, J. D. Sipe, G. Antoni, S. Silvestri & A. Tagliabue: In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1b. J Exp Med 168, 675-86 (1988)

116. D. Boraschi, G. Volpini, L.Villa, L. Nencioni, G. Scapigliati, D. Nucci, G. Antoni, G. Matteucci, F. Cioli & A. Tagliabue: A monoclonal antibody to the IL-1ß peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1ß in vivo. J Immunol 143, 131-4 (1989)

117. D. Boraschi, G. Antoni, F. Perin, L. Villa, L. Nencioni, P. Ghiara, R. Presentini & A. Tagliabue: Defining the structural requirements of a biologically active domain of human IL-1ß. Eur Cytokine Net 1, 21-6 (1990)

118. D. Boraschi, P. Ghiara, G. Scapigliati, L. Villa, A. Sette & A. Tagliabue: Binding and internalization of the 163-171 fragment of human IL-1ß. Cytokine 4, 201-4 (1992)

119. J. P. Priestle, H.-P. Schär & M. G. Grütter: Crystal structure of the cytokine interleukin-1ß. EMBO J 7, 339-43 (1988)

120. D. B. Carter, K. A. Curry, C.-S. C. Tomich, A. W. yem, M. R. Deibel, D. E. Tracey, J. W. Paslay, J. B. Carter, N. Y. Theriault, P. K. W. Harris, I. M. Reardon, H. A. Zurcher-Neely, R. L. Heinrikson, L. L. Clancy, S. W. Muchmore, K. D. Watenpaugh & H. M. Einsphar: Crystallization of purified recombinant human interleukin-1ß. Proteins Struct Funct Genet 3, 121-9 (1988)

121. S. Craig, U. Schmeissner, P. Wingfield & R. H. Pain: Conformation, stability, and folding of interleukin 1b. Biochemistry 26, 3570-6 (1987)

122. P. C. Driscoll, G. M. Clore, D. Marion, P. T. Wingfield & A. M. Gronenborn: Complete resonance assignment for the polypeptide backbone of interleukin 1b using three-dimensional heteronuclear NMR spectroscopy. Biochemistry 29, 3542-56 (1990)

123. G. M. Clore, A. Bax, P. T. Wingfield & A. M. Gronenborn: Identification and localization of bound internal water in the solution structure of interleukin 1b by heteronuclear three-dimensional 1H rotating-frame Overhauser 15N-1H multiple quantum coherence NMR spectroscopy. Biochemistry 29, 5671-6 (1990)

124. G. M. Clore, A. Bax, P. C. Driscoll, P. T. Wingfield & A. M. Gronenborn: Assignment of the side-chain 1H and 13C resonances of interleukin-1ß using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy. Biochemistry 29, 8172-84 (1990)

125. G. M. Clore, P. T. Wingfield & A. M. Gronenborn: High resolution three- dimensional structure of interleukin 1b in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy. Biochemistry 30, 2315-2323 (1990)

126. L. E. Kay, G. M. Clore, A. Bax & A. M. Gronenborn: Four-dimensional heteronuclear triple-resonance NMR spectroscopy of interleukin-1ß in solution. Science 249, 411-4 (1990)

127. G. M. Clore & A. M. Gronenborn: Structures of larger proteins in solution: three- and four-dimensional heteronuclear NMR spectroscopy. Science 252, 1390-9 (1991)

128. P. Varley, A. M. Gronenborn, H. Christensen, P. T. Wingfield, R. H. Pain & G. M. Clore: Kinetics of folding of the all-ß sheet protein interleukin-1ß. Science 260, 1110-3 (1993)

129. G. I. Makhatadze, G. M. Clore, A. M. Gronenborn & P. L. Privalov: Thermodynamics of unfolding of the all ß-sheet protein interleukin-1ß. Biochemistry 33, 9327-32 (1994)

130. J. A. Ernst, R. T. Clubb, H.-X. Zhou, A. M. Gronenborn & G. M. Clore: Demonstration of positionally disordered water within a protein hydrophobic cavity by NMR. Science 267, 1813-7 (1995)

131. A. J. Wolfson, M. Kanaoka, F. T. K. Lau & D. Ringe: Insertion of an elastase-binding loop into interleukin-1ß. Prot Engineer 4, 313-7 (1991)

132. B. J. Stockman, T. A. Scahill, M. Roy, E. L. Ulrich, N. A. Strakalaitis, D. P. Brunner, A. W. Yem & M. R. Deibel Jr: Secondary structure and topology of interleukin-1 receptor antagonist protein determined by heteronuclear three-dimensional NMR spectroscopy. Biochemistry 31, 5237-45 (1992)

133. L. L. Clancy, B. C. Finzel, A. W. Yem, M. R. Deibel Jr, N. A. Strakalaitis, D. P. Brunner, R. M. Sweet & H. M. Einsphar: Initial crystallographic analysis of a recombinant human interleukin-1 receptor antagonist protein. Acta Cryst D50, 197-201 (1994)

134. M. B. Swindells & J. M. Thornton: A study of structural determinants in the interleukin-1 fold. Prot Engineer 6, 711-5 (1993)

135. T. J. Oldfield, P. Murray-Rust & R. E. Hubbard: Model structures and action of interleukin 1 and its antagonist. Prot Engineer 6, 865-71 (1993)

136. H. Schreuder, C. Tardif, A. Soffientini, E. Sarubbi, A. Akeson, T. Bowlin, S. Yanofsky & R. W. Barrett: Crystals of soluble interleukin-1 receptor complexed with its natural antagonist reveal a 1:1 receptor-ligand complex. FEBS Lett 373, 39-40 (1995)

137. H. Schreuder: Crystal structure of the interleukin-1 receptor antagonist complex. Cytokine 7, 599 (1995)